EVALUATION of DEPRESSION in PATIENTS with BONE METASTASIS BEFORE and AFTER RADIOTHERAPY

INTRODUCTION: Bone is the third most common site of metastasis after lung and liver. Most of the bone metastases come from either prostat or breast cancers. The incidence of developing bone metastases in advanced diseases is quite high. Besides; depression is common in cancer patients with metastases. Beck Depression Inventory is used in assessment of depression in patients.
METHODS: One hundred patients were included in the study according to their primary diseases. Patients were divided into four groups and Beck depression test was performed twice to determine the depression levels of the patients before and after radiotherapy. Before radiotherapy patients were given Beck-0 and after radiotherapy they were given Beck-1
RESULTS: Results of Beck -0 and Beck -1, were statistically significant among any group itself and among all groups p<0.001. Those scores were also significant for number of bone metastases and number of radiotherapy treatment. p: <0.001.
DISCUSSION AND CONCLUSION: Depression is a common disease among the oncologhy patients, and can effect them, negatively. Beck scale scores after radiotheraphy have been found to be higher than those before radiotheraphy.